Cipla in den Nachrichten
Globaler Pharmakonzern
Tamtam hat 20 aktuelle Artikel über Cipla gefunden.
- Cipla and 3 other fundamentally strong stocks with low debt and PE less than the industry
- Stocks in news: Jio Financial, Adani Green, Nestle, Cipla, IOC, Waaree Energies
- Cipla shares rise over 1% as pharma major launches obesity, diabetes treatment drug in India
- Cipla Launches Yurpeak in India, a Weekly Tirzepatide Injection for Obesity and Diabetes
- Cipla debuts weight-loss drug Tirzepatide second brand Yurpeak
- Cipla Launches New Drug: ఊబకాయానికి సిప్లా ఔషధం
- From IndiGo, LIC, Cipla to TCS – Here are 10 stocks to watch
- Fox Mandal & Associates acts on Cipla acquiring Inzpera Healthsciences
- Cipla Launches Yurpeak for Obesity, Diabetes in India; Stock Ends 1.5% Higher
- Stocks to Watch Today – Tata Steel, Cipla, SBI and Market Highlights December 11
- Cipla launches Yurpeak (tirzepatide) for obesity and type 2 diabetes management in India
- Cipla Ltd Receives ESG Rating of 66 for FY 2024-25
- Cipla receives ESG rating of 66
- Cipla launches Yurpeak for treatment of obesity and type 2 diabetes
- Cipla launches drug for obesity, diabetes
- Cipla launches Yurpeak for obesity and type 2 diabetes
- Cipla launches Mounjaro twin 'Yurpeak' for small-town India
- Stocks to Watch Today: Tata Steel, Ashoka Buildcon, Purvankara, Prestige Estates, Cipla, SBI Life...
- Venus Remedies Receives Final 110 Mln Rupees Payment From Cipla
- Investing in Cipla (NSE:CIPLA) five years ago would have delivered you a 109% gain
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Cipla?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden